Optimization of tumor-treating field therapy for triple-negative breast cancer cells in vitro via frequency modulation
Abstract Purpose Currently, tumor-treating field (TTField) therapy utilizes a single “optimal” frequency of electric fields to achieve maximal cell death in a targeted population of cells. However, because of differences in cell size, shape, and ploidy during mitosis, optimal electric field characte...
Main Authors: | Austin R. Smothers, Jason R. Henderson, John J. O’Connell, Jonathan M. Stenbeck, Delphine Dean, Brian W. Booth |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-023-02959-x |
Similar Items
-
Efficacy and selectivity of tumor-treating field therapy for triple-negative breast cancer cells via in-house delivery device
by: Austin R. Smothers, et al.
Published: (2023-03-01) -
Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer
by: Fatma Al Qutami, et al.
Published: (2024-02-01) -
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01) -
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01) -
9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model
by: Nilufar Ali, et al.
Published: (2024-01-01)